Skip to Content

WATSON 3211 WATSON 3211 (Rivastigmine Tartrate 6 mg)

Pill with imprint WATSON 3211 WATSON 3211 is Brown & Orange, Capsule-shape and has been identified as Rivastigmine Tartrate 6 mg. It is supplied by Watson Pharmaceuticals.

Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 6 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 3211 WATSON 3211

Rivastigmine tartrate 6 mg WATSON 3211 WATSON 3211
Rivastigmine tartrate 6 mg WATSON 3211 WATSON 3211
Rivastigmine tartrate 6 mg WATSON 3211 WATSON 3211
Rivastigmine tartrate 6 mg WATSON 3211 WATSON 3211

Rivastigmine Tartrate

Imprint
WATSON 3211 WATSON 3211
Strength
6 mg
Color
Brown & Orange
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
silicon dioxide, magnesium stearate, microcrystalline cellulose, gelatin, titanium dioxide, ferric oxide yellow, ferric oxide red, ferrosoferric oxide, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, indigotindisulfonate sodium, FD&C Red No. 40, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-3211 Watson Pharmaceuticals, Inc.
63739-0579 McKesson Packaging Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.